Watanabe N - Search Results

1

A role for survivin in radioresistance of pancreatic cancer cells.

Asanuma K, Kobayashi D, Furuya D, Tsuji N, Yagihashi A, Watanabe N. Asanuma K, et al. Among authors: watanabe n. Jpn J Cancer Res. 2002 Sep;93(9):1057-62. doi: 10.1111/j.1349-7006.2002.tb02483.x. Jpn J Cancer Res. 2002. PMID: 12359060 Free PMC article.

2

Gene expression for suppressors of telomerase activity (telomeric-repeat binding factors) in breast cancer.

Saito K, Yagihashi A, Nasu S, Izawa Y, Nakamura M, Kobayashi D, Tsuji N, Watanabe N. Saito K, et al. Among authors: watanabe n. Jpn J Cancer Res. 2002 Mar;93(3):253-8. doi: 10.1111/j.1349-7006.2002.tb02166.x. Jpn J Cancer Res. 2002. PMID: 11927006 Free PMC article.

3

Survivin mRNA expression in patients with breast cancer.

Nasu S, Yagihashi A, Izawa A, Saito K, Asanuma K, Nakamura M, Kobayashi D, Okazaki M, Watanabe N. Nasu S, et al. Among authors: watanabe n. Anticancer Res. 2002 May-Jun;22(3):1839-43. Anticancer Res. 2002. PMID: 12168879

4

Relevance of c-erbB2, PLU-1 and survivin mRNA expression to diagnostic assessment of breast cancer.

Izawa A, Kobayashi D, Nasu S, Saito K, Moriai R, Asanuma K, Nakamura M, Yagihashi A, Watanabe N. Izawa A, et al. Among authors: watanabe n. Anticancer Res. 2002 Sep-Oct;22(5):2965-9. Anticancer Res. 2002. PMID: 12530026

5

Survivin as a predictor of cis-diamminedichloroplatinum sensitivity in gastric cancer patients.

Nakamura M, Tsuji N, Asanuma K, Kobayashi D, Yagihashi A, Hirata K, Torigoe T, Sato N, Watanabe N. Nakamura M, et al. Among authors: watanabe n. Cancer Sci. 2004 Jan;95(1):44-51. doi: 10.1111/j.1349-7006.2004.tb03169.x. Cancer Sci. 2004. PMID: 14720326 Free PMC article.

6

Survivin enhances Fas ligand expression via up-regulation of specificity protein 1-mediated gene transcription in colon cancer cells.

Asanuma K, Tsuji N, Endoh T, Yagihashi A, Watanabe N. Asanuma K, et al. Among authors: watanabe n. J Immunol. 2004 Mar 15;172(6):3922-9. doi: 10.4049/jimmunol.172.6.3922. J Immunol. 2004. PMID: 15004200

7

Mutations of the p53 gene and loss of heterozygosity at chromosome 17p13.1 are associated with increased survivin expression in breast cancer.

Tsuji N, Furuse K, Asanuma K, Furuya M, Kondoh K, Kamagata C, Sasaki M, Kobayashi D, Yagihashi A, Takahashi H, Watanabe N. Tsuji N, et al. Among authors: watanabe n. Breast Cancer Res Treat. 2004 Sep;87(1):23-31. doi: 10.1023/B:BREA.0000041575.73262.aa. Breast Cancer Res Treat. 2004. PMID: 15377848

8

Expression of survivin mRNA and livin mRNA in non-small-cell lung cancer.

Tanabe H, Yagihashi A, Tsuji N, Shijubo Y, Abe S, Watanabe N. Tanabe H, et al. Among authors: watanabe n. Lung Cancer. 2004 Dec;46(3):299-304. doi: 10.1016/j.lungcan.2004.05.002. Lung Cancer. 2004. PMID: 15541814

9

Survivin enhances telomerase activity via up-regulation of specificity protein 1- and c-Myc-mediated human telomerase reverse transcriptase gene transcription.

Endoh T, Tsuji N, Asanuma K, Yagihashi A, Watanabe N. Endoh T, et al. Among authors: watanabe n. Exp Cell Res. 2005 May 1;305(2):300-11. doi: 10.1016/j.yexcr.2004.12.014. Exp Cell Res. 2005. PMID: 15817155

10

Detection of autoantibodies to livin and survivin in Sera from lung cancer patients.

Yagihashi A, Asanuma K, Kobayashi D, Tsuji N, Shijubo Y, Abe S, Hirohashi Y, Torigoe T, Sato N, Watanabe N. Yagihashi A, et al. Among authors: watanabe n. Lung Cancer. 2005 May;48(2):217-21. doi: 10.1016/j.lungcan.2004.11.002. Epub 2005 Jan 8. Lung Cancer. 2005. PMID: 15829321

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,539 results

Search Page

Filters